Resultados de la búsqueda 81-90 of 3901 for villous atrophy
The purpose of this study is to find out the optimal acquisition parameters for ultrasound microvessel imaging in healthy volunteers. A Study of Ticagrelor in ...
This randomized, active controlled, multicenter Phase III open-label study is designed to evaluate the efficacy and safety of alectinib compared with ...
Comprender los problemas de salud de las mujeres, lo que incluye los riesgos principales para la salud, la menopausia, la salud de las mamas y más.
Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer cells in ...
Senescent cells contribute to age-related tissue deterioration, inflammation, and fibrosis. A group of novel frailty biomarkers obtained at the time of ...
Page 1.
This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...
Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...
A Study to Evaluate Sex and Gender in Multiple System Atrophy ... Rochester, Minn. The primary purpose of this study is to understand the influence of sex and ...
Page 1. Page 2. Page 3. Page 4. Page 5. Page 6. Page 7. Page 8.
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?